Visualitza per autor "Garassino, Marina Chiara"
Ara mostrant els elements 1-3 d 3
-
Associations of Tissue Tumor Mutational Burden and Mutational Status With Clinical Outcomes With Pembrolizumab Plus Chemotherapy Versus Chemotherapy For Metastatic NSCLC
Garassino, Marina Chiara; Novello, S.; Halmos, Balazs; Felip Font, Enriqueta; Speranza, Giovanna; Gadgeel, Shirish (Elsevier, 2023-01) -
Real-world treatment outcomes with brigatinib in patients with pretreated ALK+ metastatic non-small cell lung cancer
Popat, Sanjay; Brustugun, Odd Terje; Cadranel, Jacques; Felip Font, Enriqueta; Garassino, Marina Chiara; Griesinger, Frank (Elsevier, 2021-07) -
Tepotinib Efficacy and Safety in Patients with MET Exon 14 Skipping NSCLC: Outcomes in Patient Subgroups from the VISION Study with Relevance for Clinical Practice
Sakai, Hiroshi; Felip Font, Enriqueta; Veillon, Remi; Garassino, Marina Chiara; Raskin, Jo; Le, Xiuning (American Association for Cancer Research, 2022-03-15)